Yang X Q, Chen A J, Wang T T, Xu X F
Department of Otolaryngology Head and Neck Surgery, Beijing Civil Aviation General Hospital, Peking University Civil Aviation School of Clinical Medicine, Beijing 100123, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb 7;55(2):98-103. doi: 10.3760/cma.j.issn.1673-0860.2020.02.004.
To evaluate the clinical significance of dissection parathyroidectomy for secondary hyperparathyroidism (SHPT) in patients with renal disease on maintenance dialysis. We retrospectively reviewed 195 patients with SHPT treated in the Department of Otolaryngology & Head and Neck Surgery of Beijing Civil Aviation General Hospital between September 2009 and September 2017, including 92 males and 103 females, aged from 23 to 77 years old. There were 167 patients by operated firstly and 28 patients by operated secondly for persistent or recurrent SHPT after operation. All patients received dissection parathyroidectomy with parathyroid autograft in the sternocleidomastoid. The easement of symptoms, the levels of serum intact parathyroid hormone (iPTH), serum-ionized calcium, phosphorus, and hemoglobin were compared before and after operation. Data were analyzed by SPSS 22.0 software. Confirmed by postoperative pathology, a total of 804 hyperplastic parathyroid glands were removed in 195 patients with SHPT. Among them, 765 parathyroid glands were clearly identified and located with naked eye. The anatomic distribution of the glands showed 577 (75.4%) in the tracheoesophageal groove. The incidence of ectopic parathyroid glands was 24.6% (188/765). Other 39 (4.9%) hyperplastic parathyroid glands from 22(11.3%) patients, which were not identified and located with naked eye during operation, were pathologically detected in the dissected tissue specimens. Among 195 patients, 28(14.4%) showed supernumerary parathyroid glands. No serious complications occurred after operation. Within 6 months after the operation, the bone pain and skin itch symptoms were completely relieved and, also, the symptoms of muscle weakness, restless leg, anemia and poor sleep quality were significantly alleviated. Following-up at 6 months after surgery showed the serum levels of iPTH [(70.31±60.12) pg/ml], calium [(2.13±0.22) mmol/L], and phosphorus [(1.17±0.27) mmol/L] decreased significantly respectively compared with the preoperative serum levels of iPTH [(1 501.02±167.26) pg/ml], calium [(2.40±0.32) mmol/L], and phosphorus[(2.27±0.50)mmol/L], all with statistically significant differences (0.01); the levels of hemoglobin [(120.32±10.63) g/L] and hematocrit [(39.20±3.21)%] were higher than the preoperative levels of hemoglobin[(104.11±15.17) g/L] and hematocrit [(31.25±5.12)%], both with statistically significant differences ( valve was 12.22,18,37,respectively, all 0.05). Dissection parathyroidectomy is a beneficial and safe surgical procedure for patients with medically refractory SHPT.
评估甲状旁腺次全切除术治疗维持性透析肾病患者继发性甲状旁腺功能亢进(SHPT)的临床意义。我们回顾性分析了2009年9月至2017年9月在北京民航总医院耳鼻咽喉头颈外科接受治疗的195例SHPT患者,其中男性92例,女性103例,年龄23至77岁。167例患者首次接受手术,28例患者因术后持续性或复发性SHPT再次接受手术。所有患者均接受甲状旁腺次全切除术,并将甲状旁腺自体移植至胸锁乳突肌。比较手术前后症状缓解情况、血清全段甲状旁腺激素(iPTH)、血清离子钙、磷和血红蛋白水平。采用SPSS 22.0软件进行数据分析。术后病理证实,195例SHPT患者共切除804个增生的甲状旁腺。其中,765个甲状旁腺经肉眼清晰辨认并定位。腺体的解剖分布显示,577个(75.4%)位于气管食管沟。异位甲状旁腺的发生率为24.6%(188/765)。另外,22例(11.3%)患者的39个(4.9%)增生甲状旁腺在手术中未被肉眼辨认和定位,在切除的组织标本中经病理检测发现。195例患者中,28例(14.4%)存在甲状旁腺增生。术后未发生严重并发症。术后6个月内,骨痛和皮肤瘙痒症状完全缓解,肌肉无力、不安腿、贫血和睡眠质量差等症状也明显减轻。术后6个月随访显示,血清iPTH水平[(70.31±60.12)pg/ml]、钙水平[(2.13±0.22)mmol/L]和磷水平[(1.17±0.27)mmol/L]与术前血清iPTH水平[(1501.02±167.26)pg/ml]、钙水平[(2.40±0.32)mmol/L]和磷水平[(2.27±0.50)mmol/L]相比均显著降低,差异均有统计学意义(P<0.01);血红蛋白水平[(120.32±10.63)g/L]和血细胞比容水平[(39.20±3.21)%]高于术前血红蛋白水平[(104.11±15.17)g/L]和血细胞比容水平[(31.25±5.12)%],差异均有统计学意义(P<0.05)。甲状旁腺次全切除术对药物治疗无效的SHPT患者是一种有益且安全的手术方法。